Clinical trial Recruiting at 1 site Interventional Ages 19 to 40

Mobile phone use restriction and PET imaging of dopamine transporter

Official title: Mobile Restriction on Dopamine Transporter

Run by Pusan National University Hospital · NCT07663474 · Data updated 2026-11-12

This study tests how restricting daily mobile phone use for two weeks affects dopamine transporter binding in healthy iPhone users who can use the Screentime app.

More Addiction trials

Quick facts

Study typeInterventional
Ages19 Years to 40 Years
SexAll
Enrollment30 (estimated)
SponsorPusan National University Hospital
Academic / other
Locations1 site (Busan, Busan)
StatusRecruiting
StartedMay 1, 2026
Main results expectedDecember 31, 2029
Study endsDecember 31, 2030
Registry record updatedJune 25, 2026
Trial IDNCT07663474 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults who use an iPhone daily and can use the Screentime app, with no neuropsychiatric disease and no contraindications to PET scanning.

Probably not a fit

Individuals with neuropsychiatric conditions, on mental-health medications, or who cannot complete a four-week protocol or PET scan may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Healthy adults who regularly use mobile phones will undergo two weeks of phone restriction followed by PET scans to measure dopamine transporter binding, with a crossover period of free phone use and a second PET scan. The study uses the Screentime app to enforce and monitor restriction. PET imaging will assess changes in dopamine transporter binding related to the intervention. Participants must be able to undergo PET scanning and adhere to the two-week restriction, within a single-location setting at Pusan National University Hospital in Busan. No neuropsychiatric disorders or mental-health medications are permitted, and participation spans about four weeks in total.

Why it matters

Potential benefit: If successful, the trial could clarify how short-term changes in daily phone use may influence brain dopaminergic systems.

How similar studies have gone: Limited prior data exist for mobile-use restriction affecting dopamine transporter binding; this approach is relatively novel in humans.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy subjects with daily use of mobile phone (IPhone)
* Accessible with "Screentime" application

Exclusion Criteria:

* Neuropsychiatric disease
* Subjects who have medications for mental illness
* Subjects who cannot undergo PET scans
* Subjects who cannot participate 4 weeks of this study

Where it's running

  • Pusan National University Hospital
    Busan, Busan, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.